S. KAHRAMAN Et Al. , "Clinicopathological and survival features of neuroendocrine tumors: A retrospective analysis of 153 cases, our current remarks on a heterogeneous tumor group, and still unmet future expectations," Journal of cancer research and therapeutics , vol.19, no.2, pp.347-354, 2023
KAHRAMAN, S. Et Al. 2023. Clinicopathological and survival features of neuroendocrine tumors: A retrospective analysis of 153 cases, our current remarks on a heterogeneous tumor group, and still unmet future expectations. Journal of cancer research and therapeutics , vol.19, no.2 , 347-354.
KAHRAMAN, S., Bardakci, M., Aykan, M. B., YAŞAR, S., Erol, C., Hizal, M., ... Akinci, M. B.(2023). Clinicopathological and survival features of neuroendocrine tumors: A retrospective analysis of 153 cases, our current remarks on a heterogeneous tumor group, and still unmet future expectations. Journal of cancer research and therapeutics , vol.19, no.2, 347-354.
KAHRAMAN, SEDA Et Al. "Clinicopathological and survival features of neuroendocrine tumors: A retrospective analysis of 153 cases, our current remarks on a heterogeneous tumor group, and still unmet future expectations," Journal of cancer research and therapeutics , vol.19, no.2, 347-354, 2023
KAHRAMAN, SEDA Et Al. "Clinicopathological and survival features of neuroendocrine tumors: A retrospective analysis of 153 cases, our current remarks on a heterogeneous tumor group, and still unmet future expectations." Journal of cancer research and therapeutics , vol.19, no.2, pp.347-354, 2023
KAHRAMAN, S. Et Al. (2023) . "Clinicopathological and survival features of neuroendocrine tumors: A retrospective analysis of 153 cases, our current remarks on a heterogeneous tumor group, and still unmet future expectations." Journal of cancer research and therapeutics , vol.19, no.2, pp.347-354.
@article{article, author={SEDA KAHRAMAN Et Al. }, title={Clinicopathological and survival features of neuroendocrine tumors: A retrospective analysis of 153 cases, our current remarks on a heterogeneous tumor group, and still unmet future expectations}, journal={Journal of cancer research and therapeutics}, year=2023, pages={347-354} }